Chapters

Transcript

Video

ASCO22: Pasi Janne, MD, PhD on lung cancer research

ASCO22: Pasi Janne, MD, PhD on lung cancer research

Lung cancer research at #ASCO22. Non-small cell lung cancers with KRAS mutation respond to experimental drug adagrasib which also shows activity in brain metastasis. Dana-Farber's Pasi Janne, MD, PhD, is senior author and explains more.


Published

Created by

Dana-Farber

Related Presenters

Pasi Jänne, MD, PhD

Pasi Jänne, MD, PhD

Medical Oncology

Dr. Jänne received his MD and PhD from the University of Pennsylvania in 1996. He completed postgraduate training in internal medicine at Brigham and Women's Hospital and in medical oncology at DFCI in 2001. He is the director of the Lowe ...

View Full Profile